Identification | Back Directory | [Name]
PTUPB | [CAS]
1287761-01-6 | [Synonyms]
PTUPB 4-(5-Phenyl-3-[3-[3-(4-trifluoromethyl-phenyl)-ureido]-propyl]-pyrazol-1-yl)benzenesulfonamide 4-(5-Phenyl-3-(3-(3-(4-(trifluoromethyl)phenyl)ureido)propyl)-1H-pyrazol-1-yl)benzenesulfonamide Benzenesulfonamide, 4-[5-phenyl-3-[3-[[[[4-(trifluoromethyl)phenyl]amino]carbonyl]amino]propyl]-1H-pyrazol-1-yl]- Cyclooxygenase,inhibit,Non-alcoholic,COX,obesity,Metastasis,liver,fatty,steatosis,HUVECs,HFD,hepatic,Inhibitor,PTUPB,LLC,disease | [Molecular Formula]
C26H24F3N5O3S | [MDL Number]
MFCD32701914 | [MOL File]
1287761-01-6.mol | [Molecular Weight]
543.56 |
Chemical Properties | Back Directory | [solubility ]
DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.30 mg/ml; Ethanol: 1 mg/ml | [form ]
A solid | [color ]
White to off-white |
Hazard Information | Back Directory | [Uses]
4-(5-Phenyl-3-[3-[3-(4-trifluoromethyl-phenyl)-ureido]-propyl]-pyrazol-1-yl) benzenesulfonamide is used as a PTUPB; COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence. |
|
Company Name: |
cjbscvictory
|
Tel: |
13348960310 13348960310 |
Website: |
http://www.weikeqi-biotech.com/ |
|